Phibro Animal Health Corporation ( PAHC ) shares jumped 17.98% to $37.99 in after-hours trading on Thursday, following strong fourth-quarter results that beat expectations.

Check out the current price of PAHC stock here. 

Q4 Results Exceed Forecasts

The global animal health company reported fourth-quarter net sales of $378.7 million, up 39% year-over-year. Net income surged to $17.2 million from $0.8 million in the fourth quarter of 2024.

Adjusted Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) of Phibro reached $50.0 million, up 49% year-over-year, while adjusted diluted earnings per share of $0.57 increased 39% from $0.41 in the comparable period.

Zoetis Acquisition Drives Growth

Animal Health segment sales increased $101.0 million, or 53%, to $292.5 million in the fourth quarter. The MFAs and other product categories also delivered exceptional growth of $89.8 million, or 77%, largely attributable to $94.5 million in incremental revenues from the Zoetis MFA portfolio acquired on October 31, 2024.

See Also: Why Telomir Pharmaceuticals Stock Ran Up 35% On Wednesday Night

In the earnings statement, CEO Jack Bendheim noted that the Zoetis MFA portfolio outperformed expectations, leading to a 54% increase in MFA and Other product sales compared to last year.

Full-Year Performance Strong

For fiscal year 2025, Phibro reported net sales of $1.296 billion, up 27% from $1.018 billion in 2024. Adjusted EBITDA rose 65% to $183.7 million, and adjusted diluted EPS increased 76% to $2.09. The company ended the period with $77 million in cash and a 3.1x gross leverage ratio.

Optimistic 2026 Outlook

Management of the New Jersey-based company provided fiscal year 2026 guidance of $1.43 billion, representing 12% growth at the midpoint, and adjusted EBITDA of $225 million to $235 million, indicating 25% growth at the midpoint.

Phibro has a market capitalization of $1.31 billion and has traded between $16.16 and $32.95 over the past 52 weeks.

Price Action: According to Benzinga Pro data, PAHC closed at $32.20 on Wednesday, marking a 54.73% gain during the regular trading session.

With a strong Momentum in the 89th percentile, Benzinga’s Edge Stock Rankings indicate that PAHC has a positive price trend across all time frames. Track the performance of other players in this segment.

Read Next:

TikTok Parent Overtakes Meta In Revenue, Valuation Soars To $330 Billion Despite US Sale Pressure, Ban Threats: Report